Arghadip Samaddar, MD

Honoured and delighted to become a Fellow of the European Confederation of Medical Mycology (FECMM). Looking forward to some great collaborations and contributing to this prestigious organisation. #ECMM #FECMM

Excited to shared our recent publication “Evaluation of the Fujifilm Wako β-Glucan assay in cerebrospinal fluid for the diagnosis of non-cryptococcal fungal infections of the central nervous system”
kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...
@ishamycology.bsky.social @msgerc.bsky.social

@escmid.bsky.social @efisg-escmid.bsky.social @ishamycology.bsky.social @msgerc.bsky.social

Upcoming🔊 ESCMID Fungal Infection Study Group webinar- Under the Radar: Addressing IFIs Diagnostic Gaps in LMICs
🗓️ 23 July 2025
🕒 15:30-17:00 CET/ 19:00-20:30 (India)
Speakers: Arghadip Samaddar & Rita Oladele
Chairs: Bassey Ekeng, Anupma Kindo
💻Free registration 🔗 us06web.zoom.us/webinar/regi...

Happy to meet some wonderful colleagues & brilliant minds in Medical Mycology.
@martinhoenigl.bsky.social @germhuntermd.bsky.social at #ISHAM2025 It has been an amazing congress with enriching academic sessions, lovely food & great hospitality at such a captivating location @fozdoiguacu.bsky.social

Excited for #ISHAM2025🍄🔬🧬 I will be there for “Meet the Expert” session—Fungi in Brain: What can the medical mycology lab do for clinicians today and tomorrow?🗓️May 22. Looking forward to sharing our experiences and connecting with wonderful colleagues.
Program Link👉🏻 www.isham2025.org/resources/up...

@ishamycology.bsky.social @msgerc.bsky.social @idsainfo.bsky.social @escmid.bsky.social

Optimization of Cut-off Values for (1→3)-β-D-Glucan and Galactomannan assays in Cerebrospinal Fluid for the Diagnosis of Non-cryptococcal Fungal Infections of the Central Nervous System Abstract. Fungal infections of the central nervous system (FI-CNS) pose substantial diagnostic challenges, owing to their diverse clinical presentations an

Excited to share our latest publication “Optimization of Cutoff Values for (1→3)-β-D-Glucan & Galactomannan assays in Cerebrospinal fluid for the Diagnosis of Non-cryptococcal Fungal Infections of the Central Nervous System”
Optimal cutoffs:
BDG-72 pg/mL
GM- 0.47 ODI
academic.oup.com/mmy/advance-...

Join me at ISHAM 2025 Meet the Expert session “Fungi in Brain: What Can the Clinical Mycology Lab do for Clinicians Today and Tomorrow?” 🕗8:00-8:30 AM 🗓️May 22, Iguazu, Brazil🇧🇷
🎤Advancing Management Strategies for Cerebral Phaeohyphomycosis: The role of Multi-omics Integration in Precision Medicine.

Excited for the 15th National Biennial Conference of the Indian Society for Medical Mycologists (ISMM 2025) organised by SRIHER, Chennai, from 20-25 February 2025. Join me for an engaging session on Cerebral Phaeohyphomycosis: An Indian Scenario on 21 February 2025, 3:00-3:30 PM. Don’t miss out!

Visual abstract

Comparative efficacy and safety of treatment regimens for Pneumocystis jirovecii pneumonia in people living with HIV – A systematic review and network meta-analysis of randomized controlled trials

Hatzl et al

TLDR: “no clear best choice”

www.clinicalmicrobiologyandinfection.com/article/S119...

India’s Breakthrough: Dr. Jitendra Singh Unveils Indigenous Antibiotic Nafithromycin to Fight Drug Resistance New Delhi, Nov, 20; In a ground breaking step for India’s biotechnology sector, Union Minister Dr. Jitendra Singh today formally

On this World Antimicrobial Resistance Awareness Week, India launches her first indigenous macrolide antibiotic Nafithromycin for the treatment of drug-resistant pneumonia
asianewsobserver.com/2024/11/20/i...

Upcoming🔊BDG & its role in the management of Fungal Infections📅15 Nov 2024🕖7-9 PM (IST)/1:30-3:30 PM (CET). Join me with Martin Hoenigl,Alexandre Alanio, Anup Ghosh & Greg Kowald for understanding the clinical utility of BDG in different settings
📍Register: events.teams.microsoft.com/event/adc39a...